Avinger Inc.

2.85-0.1600-5.32%Vol 33.31K1Y Perf 131.54%
Nov 29th, 2023 16:00 DELAYED
BID2.83 ASK2.85
Open3.01 Previous Close3.01
Pre-Market- After-Market2.85
 - -  0.00 -0.02%
Target Price
7.50 
Analyst Rating
Strong Buy 1.00
Potential %
163.16 
Finscreener Ranking
★★+     47.95
Insiders Trans % 3/6/12 mo.
-/-/-100 
Value Ranking
     41.89
Insiders Value % 3/6/12 mo.
-/-/-100 
Growth Ranking
     37.44
Insiders Shares Cnt. % 3/6/12 mo.
-/-/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
-0.70 
Earnings Rating
Strong Buy
Market Cap3.90M 
Earnings Date
26th Oct 2023
Alpha-0.04 Standard Deviation0.42
Beta1.42 

Today's Price Range

2.783.01

52W Range

3.0024.30

5 Year PE Ratio Range

-0.6000-0.1000

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
-6.25%
1 Month
-28.39%
3 Months
465.45%
6 Months
407.48%
1 Year
131.54%
3 Years
872.70%
5 Years
-8.06%
10 Years
-

TickerPriceChg.Chg.%
AVGR2.85-0.1600-5.32
AAPL189.37-1.0300-0.54
GOOG136.40-2.2200-1.60
MSFT378.85-3.8500-1.01
XOM102.34-1.5600-1.50
WFC43.780.41000.95
JNJ152.110.48000.32
FB196.640.99000.51
GE118.860.01000.01
JPM154.320.78000.51
Financial StrengthValueIndustryS&P 500US Markets
2.70
3.50
0.75
3.26
-9.70
Leverage Ratio 4.30
ProfitabilityValueIndustryS&P 500US Markets
30.90
-192.70
-189.30
-295.30
-
RevenueValueIndustryS&P 500US Markets
6.27M
0.84
5.75
-6.48
Earnings HistoryEstimateReportedSurprise %
Q03 2023-2.85-2.92-2.46
Q02 2023-7.35-8.85-20.41
Q01 2023-7.35-10.64-44.76
Q04 2022--10.49-
Q03 2022--11.54-
Q02 2022-16.34-14.0913.77
Q01 2022-1.21-2.33-92.56
Q04 2021-1.26-1.260.00
Earnings Per EndEstimateRevision %Trend
12/2023 QR0.64-74.90Negative
12/2023 FY-3.5981.86Positive
3/2024 QR-3.20-12.28Negative
12/2024 FY-2.2674.02Positive
Next Report Date-
Estimated EPS Next Report-2.85
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume33.31K
Shares Outstanding1.37K
Shares Float1.27M
Trades Count384
Dollar Volume95.85K
Avg. Volume636.50K
Avg. Weekly Volume17.20K
Avg. Monthly Volume25.64K
Avg. Quarterly Volume1.87M

Avinger Inc. (NASDAQ: AVGR) stock closed at 2.85 per share at the end of the most recent trading day (a -5.32% change compared to the prior day closing price) with a volume of 33.31K shares and market capitalization of 3.90M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 81 people. Avinger Inc. CEO is Jeffrey M. Soinski.

The one-year performance of Avinger Inc. stock is 131.54%, while year-to-date (YTD) performance is 162.67%. AVGR stock has a five-year performance of -8.06%. Its 52-week range is between 3 and 24.3, which gives AVGR stock a 52-week price range ratio of -0.70%

Avinger Inc. currently has a PE ratio of -0.20, a price-to-book (PB) ratio of 1.80, a price-to-sale (PS) ratio of 1.51, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -98.96%, a ROC of -109.62% and a ROE of -379.44%. The company’s profit margin is -%, its EBITDA margin is -189.30%, and its revenue ttm is $6.27 Million , which makes it $0.84 revenue per share.

Of the last four earnings reports from Avinger Inc., there were 0 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-2.85 for the next earnings report. Avinger Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Avinger Inc. is Strong Buy (1), with a target price of $7.5, which is +163.16% compared to the current price. The earnings rating for Avinger Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Avinger Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Avinger Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 21.54, ATR14 : 0.34, CCI20 : -112.49, Chaikin Money Flow : -0.34, MACD : -0.36, Money Flow Index : 29.32, ROC : -14.49, RSI : 38.07, STOCH (14,3) : 1.28, STOCH RSI : 0.37, UO : 22.17, Williams %R : -98.72), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Avinger Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Avinger Inc.

Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO) and Pantheris, image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.

CEO: Jeffrey M. Soinski

Telephone: +1 650 241-7900

Address: 400 Chesapeake Drive, Redwood City 94063, CA, US

Number of employees: 81

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

54%46%

Bearish Bullish

60%40%

 

News

Stocktwits